0.75 CME Credits. This webinar discusses ADHD and its varied presentations, co-occurring issues, and the importance of accurate assessment for effective treatment.

0.50 CME Credits. Dr. Collier explores diagnosis, overlapping symptoms, and treatments for delirium in older adults.

0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.

0.25 CME Credits. Highlights from this month include Lumateperone, Lavender, treatment resistant smoking, and Clonidine patches and Tourettes. A new meta analysis published in Psychiatry Research sheds light on a critical question.

0.50 CME Credits. Learn how to address depression in older adults, identify the risk factors and triggers, distinguish depression from normal aging, and explore effective treatment options.

SAINT TMS is now available. We take a closer look at its record-breaking effect size.

Dr. Kenneth Levy provides an overview of the major evidence-based treatments for Borderline Personality Disorder and explains why clinicians shouldn’t limit themselves to just one model.

For years, autism care has centered on one model, but that’s changing. The American Academy of Child and Adolescent Psychiatry just redefined what evidence-based care really means. This shift could transform how we support children and families.

Owen Muir, MD, believes TMS ought to come before antidepressants for many teens with depression, but does the FDA agree with him?

Do TMS and psychotherapy share a common mechanism? We talk with Owen Muir about how to engage patients with this magnetic therapy.

Switching antipsychotics?

Sometimes, slower isn’t safer.

This is Part 3 in my A-to-Z series from the upcoming 8th edition of the Med Fact Book.

Today: Antipsychotics.

Most patients don’t stay on the first stimulant we try. Here’s how to switch safely, without the confusion.

Part 1: Med Fact Book Mini-Series

Tips from Dr. Dana Dieringer on how to document and deliver psychiatric diagnoses with care.